These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
249 related articles for article (PubMed ID: 17941951)
1. Murine models of chronic lymphocytic leukaemia: role of microRNA-16 in the New Zealand Black mouse model. Scaglione BJ; Salerno E; Balan M; Coffman F; Landgraf P; Abbasi F; Kotenko S; Marti GE; Raveche ES Br J Haematol; 2007 Dec; 139(5):645-57. PubMed ID: 17941951 [TBL] [Abstract][Full Text] [Related]
2. Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Raveche ES; Salerno E; Scaglione BJ; Manohar V; Abbasi F; Lin YC; Fredrickson T; Landgraf P; Ramachandra S; Huppi K; Toro JR; Zenger VE; Metcalf RA; Marti GE Blood; 2007 Jun; 109(12):5079-86. PubMed ID: 17351108 [TBL] [Abstract][Full Text] [Related]
3. Alterations in the mir-15a/16-1 Loci Impairs Its Processing and Augments B-1 Expansion in De Novo Mouse Model of Chronic Lymphocytic Leukemia (CLL). Kasar S; Underbayev C; Hassan M; Ilev I; Degheidy H; Bauer S; Marti G; Lutz C; Raveche E; Batish M PLoS One; 2016; 11(3):e0149331. PubMed ID: 26959643 [TBL] [Abstract][Full Text] [Related]
4. Accelerated development of chronic lymphocytic leukemia in New Zealand Black mice expressing a low level of interferon regulatory factor 4. Ma S; Shukla V; Fang L; Gould KA; Joshi SS; Lu R J Biol Chem; 2013 Sep; 288(37):26430-40. PubMed ID: 23897826 [TBL] [Abstract][Full Text] [Related]
5. The New Zealand black mouse as a model for the development and progression of chronic lymphocytic leukemia. Salerno E; Yuan Y; Scaglione BJ; Marti G; Jankovic A; Mazzella F; Laurindo MF; Despres D; Baskar S; Rader C; Raveche E Cytometry B Clin Cytom; 2010; 78 Suppl 1(Suppl 1):S98-109. PubMed ID: 20839343 [TBL] [Abstract][Full Text] [Related]
6. Correcting miR-15a/16 genetic defect in New Zealand Black mouse model of CLL enhances drug sensitivity. Salerno E; Scaglione BJ; Coffman FD; Brown BD; Baccarini A; Fernandes H; Marti G; Raveche ES Mol Cancer Ther; 2009 Sep; 8(9):2684-92. PubMed ID: 19723889 [TBL] [Abstract][Full Text] [Related]
7. Therapeutic implications of activation of the host gene (Dleu2) promoter for miR-15a/16-1 in chronic lymphocytic leukemia. Kasar S; Underbayev C; Yuan Y; Hanlon M; Aly S; Khan H; Chang V; Batish M; Gavrilova T; Badiane F; Degheidy H; Marti G; Raveche E Oncogene; 2014 Jun; 33(25):3307-15. PubMed ID: 23995789 [TBL] [Abstract][Full Text] [Related]
8. Systemic in vivo lentiviral delivery of miR-15a/16 reduces malignancy in the NZB de novo mouse model of chronic lymphocytic leukemia. Kasar S; Salerno E; Yuan Y; Underbayev C; Vollenweider D; Laurindo MF; Fernandes H; Bonci D; Addario A; Mazzella F; Raveche E Genes Immun; 2012 Feb; 13(2):109-19. PubMed ID: 21881595 [TBL] [Abstract][Full Text] [Related]
9. Role of mir-15a/16-1 in early B cell development in a mouse model of chronic lymphocytic leukemia. Underbayev C; Kasar S; Ruezinsky W; Degheidy H; Schneider JS; Marti G; Bauer SR; Fraidenraich D; Lightfoote MM; Parashar V; Raveche E; Batish M Oncotarget; 2016 Sep; 7(38):60986-60999. PubMed ID: 27533467 [TBL] [Abstract][Full Text] [Related]
10. The NZB mouse as a model for chronic lymphocytic leukemia. Phillips JA; Mehta K; Fernandez C; Raveché ES Cancer Res; 1992 Jan; 52(2):437-43. PubMed ID: 1370214 [TBL] [Abstract][Full Text] [Related]
11. The Perez-Chacon G; Zapata JM Front Immunol; 2021; 12():627602. PubMed ID: 33912159 [TBL] [Abstract][Full Text] [Related]
12. H-2z homozygous New Zealand mice as a model for B-cell chronic lymphocytic leukemia: elevated bcl-2 expression in CD5 B cells at premalignant and malignant stages. Okamoto H; Nishimura H; Shinozaki A; Zhang D; Hirose S; Shirai T Jpn J Cancer Res; 1993 Dec; 84(12):1273-8. PubMed ID: 7507474 [TBL] [Abstract][Full Text] [Related]
14. Regulatory role of T cells in a murine model of lymphoproliferative disease. Raveche E; Fernandes H; Ong H; Peng B Cell Immunol; 1998 Jul; 187(1):67-75. PubMed ID: 9682005 [TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in the pathogeny of chronic lymphocytic leukaemia. Nicoloso MS; Kipps TJ; Croce CM; Calin GA Br J Haematol; 2007 Dec; 139(5):709-16. PubMed ID: 18021085 [TBL] [Abstract][Full Text] [Related]
16. microRNA-34a expression correlates with MDM2 SNP309 polymorphism and treatment-free survival in chronic lymphocytic leukemia. Asslaber D; Piñón JD; Seyfried I; Desch P; Stöcher M; Tinhofer I; Egle A; Merkel O; Greil R Blood; 2010 May; 115(21):4191-7. PubMed ID: 20089965 [TBL] [Abstract][Full Text] [Related]
17. Chronic lymphocytic leukemia: molecular genetics and animal models. Pekarsky Y; Calin GA; Aqeilan R Curr Top Microbiol Immunol; 2005; 294():51-70. PubMed ID: 16323427 [TBL] [Abstract][Full Text] [Related]
18. Synergistic Activity of Deguelin and Fludarabine in Cells from Chronic Lymphocytic Leukemia Patients and in the New Zealand Black Murine Model. Rebolleda N; Losada-Fernandez I; Perez-Chacon G; Castejon R; Rosado S; Morado M; Vallejo-Cremades MT; Martinez A; Vargas-Nuñez JA; Perez-Aciego P PLoS One; 2016; 11(4):e0154159. PubMed ID: 27101369 [TBL] [Abstract][Full Text] [Related]
19. Genetic factors predisposing to B-CLL and to autoimmune disease in spontaneous murine model. Hirose S; Hamano Y; Shirai T Leukemia; 1997 Apr; 11 Suppl 3():267-70. PubMed ID: 9209361 [TBL] [Abstract][Full Text] [Related]
20. The correlation of telomerase and IL-10 with leukemia transformation in a mouse model of chronic lymphocytic leukemia (CLL). Peng B; Zhang M; Sun R; Lin YC; Chong SY; Lai H; Stein D; Raveche ES Leuk Res; 1998 Jun; 22(6):509-16. PubMed ID: 9678717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]